Myriad Genetics Inc (MYGN)
25.27
+1.32
(+5.51%)
USD |
NASDAQ |
May 09, 16:00
25.20
-0.07
(-0.28%)
Pre-Market: 09:19
Myriad Genetics Accounts Receivable (Quarterly): 114.30M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 114.30M |
September 30, 2023 | 115.20M |
June 30, 2023 | 111.70M |
March 31, 2023 | 119.10M |
December 31, 2022 | 101.60M |
September 30, 2022 | 102.20M |
June 30, 2022 | 109.80M |
March 31, 2022 | 101.70M |
December 31, 2021 | 91.30M |
September 30, 2021 | 93.60M |
June 30, 2021 | 94.80M |
March 31, 2021 | 94.10M |
September 30, 2020 | 85.10M |
June 30, 2020 | 68.10M |
March 31, 2020 | 102.50M |
December 31, 2019 | 118.30M |
September 30, 2019 | 117.00M |
June 30, 2019 | 133.90M |
March 31, 2019 | 142.60M |
December 31, 2018 | 116.60M |
September 30, 2018 | 119.10M |
June 30, 2018 | 99.50M |
March 31, 2018 | 123.70M |
December 31, 2017 | 121.10M |
September 30, 2017 | 113.20M |
Date | Value |
---|---|
June 30, 2017 | 90.20M |
March 31, 2017 | 114.80M |
December 31, 2016 | 107.60M |
September 30, 2016 | 98.20M |
June 30, 2016 | 91.70M |
March 31, 2016 | 91.10M |
December 31, 2015 | 84.30M |
September 30, 2015 | 83.40M |
June 30, 2015 | 85.80M |
March 31, 2015 | 92.20M |
December 31, 2014 | 81.22M |
September 30, 2014 | 75.72M |
June 30, 2014 | 81.90M |
March 31, 2014 | 82.68M |
December 31, 2013 | 84.14M |
September 30, 2013 | 86.22M |
June 30, 2013 | 94.33M |
March 31, 2013 | 93.17M |
December 31, 2012 | 75.56M |
September 30, 2012 | 62.50M |
June 30, 2012 | 60.44M |
March 31, 2012 | 50.95M |
December 31, 2011 | 42.99M |
September 30, 2011 | 44.82M |
June 30, 2011 | 50.27M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
68.10M
Minimum
Jun 2020
133.90M
Maximum
Jun 2019
104.13M
Average
102.35M
Median
Accounts Receivable (Quarterly) Benchmarks
Stryker Corp | 3.473B |
Perspective Therapeutics Inc | 1.165M |
Electromed Inc | 22.99M |
Xtant Medical Holdings Inc | 20.73M |
Asensus Surgical Inc | 3.508M |